APIMEDS PHARMACEUTICALS US, INC. (APUS) Operating cash flow 2023–2025
APIMEDS PHARMACEUTICALS US, INC. (APUS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.9MFY2025 · since FY2023: -$627,790 → -$8.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.9M | -1116.8% |
| FY2024 | -$733,526 | -16.8% |
| FY2023 | -$627,790 | — |
Source: SEC XBRL filings · For reference only · Not investment advice